Crinetics Pharmaceuticals Inc (CRNX) — Financial Flexibility Index
Crinetics Pharmaceuticals Inc (CRNX) has a Financial Flexibility Index of -0.72x as of June 2026. Free cash flow of $-93.67 Million (operating CF $-94.19 Million minus capex $521.00K) represents -1% of total liabilities ($129.92 Million). Check how tangible is Crinetics Pharmaceuticals Inc's equity to evaluate the tangible quality of the company's equity base.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Crinetics Pharmaceuticals Inc Financial Flexibility Index (2016–2025)
Historical Financial Flexibility Index trend for Crinetics Pharmaceuticals Inc across 10 annual periods. For the full cash flow conversion analysis, see Crinetics Pharmaceuticals Inc (CRNX) cash conversion ratio.
Annual Financial Flexibility Index for Crinetics Pharmaceuticals Inc (2016–2025)
Year-by-year free cash flow to debt coverage for Crinetics Pharmaceuticals Inc. Explore Crinetics Pharmaceuticals Inc (CRNX) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -2.60x | $-372.16 Million | $-377.92 Million | $143.41 Million | ▼ -28.3% |
| 2024 | -2.02x | $-222.13 Million | $-225.97 Million | $109.79 Million | ▼ -20.5% |
| 2023 | -1.68x | $-161.62 Million | $-166.31 Million | $96.25 Million | ▲ +47.0% |
| 2022 | -3.17x | $-113.55 Million | $-115.20 Million | $35.85 Million | ▲ +31.5% |
| 2021 | -4.62x | $-88.15 Million | $-88.59 Million | $19.07 Million | ▼ -8.6% |
| 2020 | -4.26x | $-61.84 Million | $-62.03 Million | $14.53 Million | ▼ -22.8% |
| 2019 | -3.47x | $-45.89 Million | $-46.38 Million | $13.24 Million | ▼ -110.8% |
| 2018 | -1.64x | $-18.40 Million | $-19.46 Million | $11.19 Million | ▼ -448.8% |
| 2017 | -0.30x | $-9.18 Million | $-9.48 Million | $30.62 Million | ▼ -6.7% |
| 2016 | -0.28x | $-5.28 Million | $-5.47 Million | $18.80 Million | — |